An Ergocryptine as a Lactation Inhibitor
- 1 January 1974
- journal article
- clinical trial
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 5 (3) , 133-138
- https://doi.org/10.1159/000301647
Abstract
A double-blind trial was performed on 40 parturient women to compare the efficacy of an ergocryptine (CB 154) as a lactation inhibitor in comparision with chlorotrianisine (TACE). The two drugs were about equally effective. The drug CB 154 is unlikely to be associated with puerperal thrombo-embolism, it does not seem to be followed by rebound lactation, and it may prove particularly effective in women with a previous history of puerperal mastitis or breast engorgement.Keywords
This publication has 0 references indexed in Scilit: